NLRP3 and colitis: In a mouse model of dextran sulfate sodium (DSS)-induced colitis, genistein significantly suppressed NLRP3 inflammasome activation via the TGR5–cAMP signaling axis, leading to reduced IL-1β secretion and improved clinical outcomes [44].